Vectorb2b

Executive Summary

VectorB2B is a full-service Contract Research Organization (CRO) headquartered in Lisbon, Portugal, providing integrated pre-clinical and clinical development services for drugs, biologics, and medical devices. Founded in 2019, the company acts as a strategic partner for biotechnology, pharmaceutical, and medical device firms, leveraging a network of academic and industrial collaborators to deliver cost-effective scientific expertise. With a focus on supporting clients from discovery through clinical trials, VectorB2B offers a comprehensive suite of services including study design, regulatory support, data management, and clinical operations. The company operates in the competitive CRO market, emphasizing its ability to provide tailored solutions while maintaining high quality standards. Despite being privately held with no disclosed funding, VectorB2B positions itself as a nimble and efficient alternative to larger CROs, targeting mid-sized and emerging life science companies seeking flexible partnerships.

Upcoming Catalysts (preview)

• Q4 2026Announcement of Major Partnership with Top-20 Pharma Company15% success
• Q3 2026ISO 9001:2025 Certification for Quality Management30% success
• Q2 2027Expansion into Central and Eastern European Clinical Trial Sites25% success